Apella Capital, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1801507
WEST HARTFORD, CT
Position in VRTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$299,528
New position
Shares Held
603
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#153
of 250 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Apella Capital, LLC holds $7,226,690 across 7 Biotechnology names. VRTX ranks #4 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
382,284 | $4,809,132 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
26,658 | $991,944 | |
| 3 | AVXL |
Anavex Life Sciences Corp.
|
227,995 | $590,507 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
603 | $299,528 | |
| 5 | NERV |
Minerva Neurosciences, Inc.
|
42,250 | $234,487 | |
| 6 | PGEN |
Precigen, Inc.
|
28,985 | $165,214 | |
| 7 | OMER |
Omeros Corp
|
14,288 | $135,878 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,528 | 603 | Shares | Sole | 2026-07-08 | |
| No filing history on record for this holder in this stock. | ||||||